FDA expands approval for GSK’s RSV vaccine to cover younger at-risk adults
Posted:
The Food and Drug Administration expanded the approval for GSK’s vaccine to protect against respiratory syncytial virus, or RSV, authorizing its use for at-risk adults as young as 50.
Microsoft announced a strategic partnership with Mayo Clinic to develop and deploy a frontier AI model specifically for healthcare, combining Mayo Clinic's clinical expertise with the tech giant's technologies.
Read more here.
Healthcare is evolving faster than ever — driven by digital transformation, AI, new care models, and increasing pressure on health systems to deliver better outcomes with fewer resources.
But innovation only works when the right people come together in the…
Attendees
Sponsors and Exhibitors
Contact us